Comparative study between sonography, pathology and UGP in women with perimenopausal bleeding

Anticancer Research

Volumn 16, Issue 4 B, 1996, Pages 2309-2313

  El Ahmady, Omar ^a   Gad, Monira ^a   El Sheimy, Refaat ^a   Halim, Abdel Baset ^a   Eissa, Saad ^b   Hassan, Fatma ^a   Walker, Roger ^c  

^a AL AZHAR UNIVERSITY   (Egypt)

^b NATIONAL CANCER INSTITUTE   (Egypt)

^c Ciba Corning Diagnostica   (United States)

Author keywords

Endometrium; Pathology; Perimenopausal bleeding; Sonography; UGP

Indexed keywords

CHORIONIC GONADOTROPIN; DNA;

ADENOMA; ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DNA DETERMINATION; DOPPLER FLOWMETRY; ECHOGRAPHY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATHOLOGY; PLOIDY; PRIORITY JOURNAL; RISK; UTERINE ARTERY;

ADENOCARCINOMA; ADULT; AGED; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DNA, NEOPLASM; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PEPTIDE FRAGMENTS; UTERINE HEMORRHAGE;

EID: 0029840721     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mencaglia, L., Valle, R.F., Perino, A., and Gilardia, G: Endometrial carcinoma and its precursors: early detection and treatment. Int J Gynecol 31: 107-116, 1990.
2. Granberg S, Wikland K, Karlsson B: Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality. Am J Obstet Gynecol 164: 47-52, 1991.
3. Nasri MN, Shepherd JH, Setchell ME and Chard T: The role of vaginal scan in measurement of endometrial thickness in postmenopausal women. Br J Obstet Gynecol 98: 470, 1991.
4. Fleischer AC, Kalemeris Gc, Machin JE, Entman SS, James AE Jr: Sonographic depiction of normal and abnormal endometrium with histopathologic correlation. J Ultrasound Med 5: 445-452, 1986.
5. Osmers R, Volksen M, Schauer A: Vaginosonography for early detection of endometrial carcinoma. Int J Gynecol Obstet 335: 1569-1571, 1990.
6. Rosenberg P, Wingren S, Simorsen E, Stal O, Risberg B, Nordernsk Jold B: Flow cytometric measurements of DNA index and S-phase on paraffin embedded early stage endometrial cancer: an important prognostic indicator. Gynecol Oncol 35: 50-54, 1989.
7. Hedly DW, Rugg CA, Gelber RD: Association of DNA index and S-phase fraction with prognosis in nodes positive early breast cancer. Cancer Res 47: 4729-4735, 1987.
8. Punnonen R, Mattila J, Kuoppala T, Koivula T: DNA ploidy, cell proliferation and steroid hormone receptors in endometrial hyperplasia and early adenocarcinoma. J Cancer Res Clin Oncol 149: 426-429, 1993.
9. Beastall GH, Cook B, Rustin GJ and Jennings J: A review of the role of established tumor markers. Ann Clin Biochem 28: 5, 1991.
10. Daar AS and Woodruff M (eds): Tumor markers in clinical practice. Concepts and applications. Blackwell scientific publiations, Oxford, pp. 206-225, 1987.
11. Birken S, Armstrong EG, Gawinomicz-Kolks MA, Cole LA, Agosto GM, Krickevsky A, Vaitukaitis JL and Canfield RE: Structure of human chorionic gonadotropin ß-subunit core fragment from pregnancy urine. Endocrinol 123: 572-583, 1988.
12. Franchimont P, Gaspard U, Reuter A and Heynen G: Polymorphism of protein and polypeptide hormones. Clin Endocrinol 1: 315-336, 1972.
13. Kato Y and Braunstein GD: ß-core fragment is a major form of immunoreactive urinary chorionic gonadotropin in human prgnancy. J Clin Endocrinol Metab 66: 1197-1201, 1988.
14. Cole LA, Wang Y, Elliott M, Latif M, Chambero JT, Chambers SC and Schwartz PE: Urinary human chorionic gonadotropin free ß-subunit and ß-core fragment: A new marker of gynecological cancers. Cancer Res 48: 1356-1360, 1988.
15. Normon RJ, Buck RH, Akar B and Mayet N: Detection of a small molecular species of human chorionic gonadotropin in the urine of patients with carcinoma of the cervix and cervical intraeptithelial neoplasia: Comparison with other assays for human chorionic gonadotropin and its fragments. Gynecol Oncol 37: 254-259, 1990.
16. Nam JH, Calke LA, Chambers JT, Schwartz PE: Urinary gonadotropin fragment, a new tumor marker: I. Assay development and cancer specificity. Gynecol Oncol 36: 343-390, 1990a.
17. Nam JH, Chang KC, Chambers JT, Schwartz PE and Cole LA: Urinary gonadotropin fragment, a new tumor marker: III: use in cervical and vulvar cancers. Gynecol Oncol 38: 66-70, 1990b.
18. McGill J, Cole LA, Narm JH and Thorson A: Urinary gonadotropin fragment (UGF): a potential marker of colorectal cancer. J tumor Marker Oncol 5: 175-177, 1990.
19. Alfthan H, Haglund C, Roberts P and Stenman UH: Elevation of free beta subunit of human chorionic gonadoropin and core beta fragment of human chorionic gonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res 52: 4628-4633, 1992.
20. Eneroth CM and Zetterberg A: Relationship between the nuclear DNA content in smears of aspirates and the prognosis of mucoepidermoid carcinoma. Acta Otolaryngol 80: 429, 1974.
21. Schonfeld A, Levavi H, Hirsch M: Transvaginal sonography in postmenopausal women. J Clin Ultrasound 18: 350-358, 1990.
22. Nasri MN and Coast GJ: Correlation of ultrasound findings and endometrial histopathology in postmenopausal women. Br J Obstet Gynecol 96: 1333-1338, 1989.
23. Kurjak A, Shalan H, Sosic A, Benic Stj, Zudeniger D, Kupesics and Predanic M: Endometrial carcinoma in postmenopausal women. Evaluation by transvaginal color Doppler ultrasonography. Obstet Gynecol 169: 1597-1603, 1993.
24. Weiner Z, Beck D, Rotten S, Joseph M, Brand S and Thaler I: Uterine artery flow velocity waveforms and color flow imaging in women with perimenopausal and postmenopausal bleeding. Acta Obstet Scand 72: 162-166, 1993.
25. Bourne TH, Campbell S, Steer CV: Detection of endometrial cancer by transvaginal ultrasonography with color flow imaging and blood flow analysis: A preliminary report. Gynecol Oncol 40: 253-259, 1990.
26. Kurjak A, Zalud, Alfirevic Z, Jurocvic D: The assessment of abnormal pelvic blood flow by transvaginal color Doppler Ultrasound Med Biol 16: 437-442, 1990.
27. Izumi S, Yamaolca K, Arai H and Watanabe: Flow cytometric DNA analysis of uterine endometrial carcinoma. NipponSunka-Fujinka-Gakkai-Zasshi 43: 722, 1991.
28. Iversen OE: Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma. Am J Obstet Gynecol 155: 770-776, 1986.
29. O'Connor JF, Schlatterer PE, Birkein S, Krichensky A, Armstrong G, McMahon D and Confield RE: Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its ß-subunit, and ß-core fregment in the urine: Application to malignancies. Cancer Res 48: 1361-1366, 1988.
30. Lee C, lies R, Shepherd JH, Hudson CN and Chard T: The purification and development of radioimmunoassay for ß-core fragment of human chrionic gonadotropin in urine: Application as a marker of gynecological cancer in premenopausal and postmenopausal women. J Endocrinol 130: 481-489, 1991.